logo

For the Inventor, By the Inventor

Framingham, MA, United States of America

Bpgbio, Inc.

USPTO Granted Patents = 11


Trademarks = 7

Forward Citations = 3

Loading Chart...
Loading Chart...

24 inventors (with patents filed for the assignee):

goldMedal Niven Rajin Narain (9 out of 51 patents)

silverMedal Rangaprasad Sarangarajan (6 out of 30 patents)

bronzeMedal Viatcheslav R Akmaev (4 out of 13 patents)

4.  Michael Andrew Kiebish (3 out of 6 patents)

5.  John Patrick McCook (2 out of 25 patents)

6.  Vijetha Vemulapalli (2 out of 3 patents)

7.  Vivek K Vishnudas (2 out of 2 patents)

8.  Joaquin J Jimenez (1 out of 15 patents)

9.  Thomas Mitchell Gray (1 out of 4 patents)

10.  Shiv Srivastava (1 out of 22 patents)

11.  Wenfang Sybil Wu (1 out of 2 patents)

12.  Shobha Ravipaty (1 out of 2 patents)

13.  Tracey Friss (1 out of 2 patents)

14.  Albert Dobi (1 out of 9 patents)

15.  Min Du (1 out of 3 patents)


11 patents:

1. 12691081 - Methods for the treatment of cancer using coenzyme Q10 combination therapies (2026-07-28),
2. 12653776 - Methods of treatment of cancer by continuous infusion of coenzyme Q10 (2026-06-16),
3. 12626169 - Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data (2026-05-12),
4. 12616666 - Coenzyme Q10 formulations in the treatment and prevention of epidermolysis bullosa (2026-05-05),
5. 12437835 - Interrogatory cell-based assays and uses thereof (2025-10-07),
6. 12329726 - Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders (2025-06-17),
7. 12320812 - Markers for the diagnosis of biochemical recurrence in prostate cancer (2025-06-03),
8. 12303471 - Methods of treatment of temozolomide-resistant glioma using coenzyme Q10 (2025-05-20),
9. 12209285 - Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10) (2025-01-28),
10. 11866487 - Filamin A binding proteins and uses thereof (2024-01-09),
11. 11734593 - Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data (2023-08-22),
Company Overview
Bpgbio, Inc. is a biotechnology company based in Framingham, MA, specializing in the development of innovative solutions for the treatment of various diseases. The organization focuses on advancing therapeutic modalities through cutting-edge research in molecular biology and biochemistry. Bpgbio aims to address unmet medical needs by leveraging its expertise in drug discovery and development, contributing to the evolution of healthcare and improving patient outcomes through its scientific advancements.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

11 Patents

#22 in Framingham, MA

#1,661 in Massachusetts

#27,529 in US

#51,801 in the World

Framingham, MA (US)
Framingham, MA, United States of America

Bpgbio, Inc.

Forward Citations = 3

24 inventors:

goldMedal Niven Rajin Narain (9 out of 51 patents)

silverMedal Rangaprasad Sarangarajan (6 out of 30 patents)

bronzeMedal Viatcheslav R Akmaev (4 out of 13 patents)

4.  Michael Andrew Kiebish (3 out of 6 patents)

5.  John Patrick McCook (2 out of 25 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bpgbio, Inc.. Retrieved from https://idiyas.com/company/bpgbio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…